{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:36:43Z","timestamp":1784432203086,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.jneuroim.2005.04.001","type":"journal-article","created":{"date-parts":[[2005,5,18]],"date-time":"2005-05-18T07:58:54Z","timestamp":1116403134000},"page":"161-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["P\/Q-type calcium channel antibodies, Lambert\u2013Eaton myasthenic syndrome and survival in small cell lung cancer"],"prefix":"10.1016","volume":"164","author":[{"given":"Paul W.","family":"Wirtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arn M.J.M.","family":"van den Maagdenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia A.","family":"de Koning Gans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Twijnstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.04.001_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.410270515","article-title":"Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer\u2014a quantitative western blot analysis","volume":"27","author":"Dalmau","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.04.001_bib2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.04.001_bib3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert\u2013Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.04.001_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(05)76153-5","article-title":"Favourable prognosis in Lambert\u2013Eaton myasthenic syndrome and small-cell lung carcinoma","volume":"353","author":"Maddison","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2005.04.001_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","article-title":"Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert\u2013Eaton myasthenic syndrome","volume":"120","author":"Mason","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.04.001_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2004.01.028","article-title":"Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer","volume":"22","author":"Monstad","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2005.04.001_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/Q-type and anti-N-type calcium channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2005.04.001_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.04.001_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6","article-title":"Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years","volume":"89","author":"Paesmans","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2005.04.001_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mus.10087","article-title":"The action of Lambert\u2013Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels","volume":"25","author":"Pinto","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2005.04.001_bib11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00415-003-1063-7","article-title":"The epidemiology of myasthenia gravis, Lambert\u2013Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland","volume":"250","author":"Wirtz","year":"2003","journal-title":"J. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:01:21Z","timestamp":1759046481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557280500130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":11,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S016557280500130X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.04.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P\/Q-type calcium channel antibodies, Lambert\u2013Eaton myasthenic syndrome and survival in small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}